[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"General Hospital Sveti Duh\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":66},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,45],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":26,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":40,"leadSponsor":42,"locationsCount":4},"100614281","turp-outcome-prediction-calculator-study-100614281",false,"NCT07277556","TURP Outcome Prediction Calculator Study","Identification of Predictive Parameters for Developing a TURP Outcome Calculator for Preoperative Patient Assessment","TURP-SCORE","Inclusion Criteria:\n\n* Male patients aged 18 years or older\n* Clinical diagnosis of benign prostatic hyperplasia (BPH)\n* Indication for TURP based on symptoms or complications\n* Completed preoperative evaluation (IPSS, ultrasound, PSA, uroflowmetry)\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Suspected or confirmed prostate cancer\n* No clinical evidence of BPH\n* Prior urodynamic diagnosis of underactive\u002Fneurogenic bladder\n* Prior prostate surgery\n* Inability to participate in follow-up","MALE","18 Years",{"count":20,"type":21},200,"ESTIMATED","OBSERVATIONAL","The goal of this observational study is to identify which preoperative clinical, ultrasound, and uroflowmetry parameters can help predict the success of transurethral resection of the prostate (TURP) in adult male patients with symptomatic benign prostatic hyperplasia (BPH). The main questions it aims to answer are:\n\nWhich preoperative parameters (IPSS, prostate volume, post-void residual urine, Qmax, comorbidities) are associated with successful postoperative outcomes?\n\nCan these parameters be used to develop a non-invasive calculator to estimate the likelihood of TURP success?\n\nParticipants will undergo routine clinical evaluation that is part of standard care, including:\n\n* completion of the IPSS questionnaire\n* digital rectal examination\n* ultrasound measurement of prostate volume and residual urine\n* uroflowmetry (Qmax and voided volume)\n* standard laboratory testing Eligible participants will then undergo TURP as clinically indicated and return for postoperative assessments of symptom improvement and urinary flow parameters.",[25],"Benign Prostatic Hyperplasia (BPH)",[27,28,29,30,31,32],"BPH","LUTS","TURP","Uroflowmetry","IPSS","Outcome Prediction","NOT_YET_RECRUITING","2025-12-15",{"date":36,"type":37},"2025-12-19","ACTUAL",{"date":39,"type":21},"2026-03-02",{"date":41,"type":21},"2027-12-13",{"name":43,"class":44},"General Hospital Sveti Duh","OTHER",{"id":46,"slug":47,"hasResults":11,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":51,"eligibilityCriteria":52,"healthyVolunteers":11,"sex":53,"minAge":18,"maxAge":4,"enrollmentInfo":54,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":56,"conditions":57,"keywords":4,"overallStatus":33,"whyStopped":4,"lastUpdateSubmitDate":59,"lastUpdatePostDateStruct":60,"startDateStruct":62,"completionDateStruct":63,"leadSponsor":65,"locationsCount":4},"100614885","sarcopenia-and-nmibc-prognosis-study-100614885","NCT07285408","Sarcopenia and NMIBC Prognosis Study","Impact of Body Composition, Sarcopenia, Myosteatosis, and Nutritional Status on Recurrence and Progression in Patients With Non-Muscle-Invasive Bladder Cancer: A Prospective Observational Study","SARC-NMIBC","Inclusion Criteria:\n\n* Adults aged 18 years or older\n* Histologically confirmed non-muscle-invasive bladder cancer (NMIBC) (Ta, T1, or CIS)\n* Scheduled for transurethral resection of bladder tumor (TURBT) as part of standard care\n* Able to undergo CT imaging required for assessment of skeletal muscle index (SMI) and skeletal muscle density (SMD)\n* Completed preoperative clinical evaluation including: SARC-F, NRS, anthropometric measurements (BMI, waist circumference), serum albumin, and routine laboratory tests\n* Able and willing to provide written informed consent\n\nExclusion Criteria:\n\n* Low-risk NMIBC, as defined by clinical guidelines\n* Muscle-invasive bladder cancer (≥ T2) at diagnosis\n* Expected survival less than 3 months\n* Contraindications to CT imaging (e.g., severe renal dysfunction, contrast allergy if contrast required)\n* Age under 18 years\n* Inability or unwillingness to adhere to scheduled follow-up\n* Any condition that, in the investigator's judgment, would interfere with participation or data integrity","ALL",{"count":55,"type":21},150,"The goal of this observational study is to evaluate whether body composition abnormalities (sarcopenia, myosteatosis, and obesity) and nutritional status influence the risk of recurrence and progression in adult patients with non-muscle-invasive bladder cancer (NMIBC). The main questions it aims to answer are:\n\nDo sarcopenia, myosteatosis, obesity, or malnutrition increase the likelihood of NMIBC recurrence and progression?\n\nCan clinical, laboratory, and CT-derived body composition parameters serve as predictive biomarkers that improve individualized risk stratification?\n\nParticipants will undergo routine clinical and radiologic assessments, including:\n\n* completion of the SARC-F and NRS nutritional screening questionnaires\n* anthropometric measurements (BMI, waist circumference)\n* laboratory evaluation including serum albumin and testosterone\n* CT-based assessment of skeletal muscle index (SMI) and muscle density (SMD)\n* standard TURBT and structured follow-up with cystoscopy, cytology, imaging, and clinical evaluations to document recurrence and progression.",[58],"Bladder Cancer Cell Transitional","2025-12-12",{"date":61,"type":37},"2025-12-16",{"date":39,"type":21},{"date":64,"type":21},"2029-07-09",{"name":43,"class":44},""]